Dr. Jaime Sepúlveda, director of the Institute for Global Health at the University of California, explains that when the clinical trials of the COVID-19 vaccine carried out by the pharmaceutical company conclude, they will be able to undergo FDA approval.March 16, 2021
Expert estimates that in two months the trials in children of Moderna's vaccine will be ready
2021-03-16T19:25:50.796Z
Dr. Jaime Sepúlveda, director of the Institute for Global Health at the University of California, explains that when the clinical trials of the COVID-19 vaccine carried out by the pharmaceutical company are completed, they will be able to undergo FDA approval.